Progyny's earnings call reflects strong financial performance and growth potential, highlighted by record revenues, expanded partnerships, and a raised guidance. However, challenges include the transition of a large client and macroeconomic uncertainties impacting pipeline growth. Despite these challenges, the company's strategic expansions and diversified client base provide a positive outlook.

Company Guidance -

Q2 2025

During the first quarter 2025 earnings call, Progyny Inc. reported robust financial results with double-digit growth in both revenue and adjusted EBITDA compared to the prior year. Revenue increased 16.5% to $324 million, driven primarily by an uptick in the number of clients and covered lives. The company saw a record 16,160 ART cycles, reflecting a 9% growth year-over-year. Progyny raised its full-year guidance, projecting revenue between $1.185 billion and $1.235 billion and adjusted EBITDA between $190 million and $203 million. The guidance assumes a contribution of $44 million to $46 million from a large client under a transition of care agreement. The company also reported record gross margins and significant quarterly cash flow, with a focus on expanding its product portfolio and platform to enhance member experience. With stable utilization rates and a diversified client base across 45 industries, Progyny remains optimistic about its growth trajectory and market position in women's health and family building solutions.

Strong Revenue Growth and Guidance Increase

First quarter revenue grew 16.5% to $324 million, primarily due to an increase in the number of clients and covered lives. Full-year guidance has been raised, projecting revenue growth between 1.5% and 5.8% with expectations excluding a large client to be 11% to 15%.

Record Quarterly Results and Cash Flow

The company reported record quarterly results for both revenue and adjusted EBITDA, along with significant quarterly cash flow generation, nearly doubling operating cash flow compared to the prior year.

Expansion of Product Portfolio and Partnerships

Progyny made meaningful progress in expanding its product portfolio and platform, enhancing member experience, and extending its position in women's health and family building. New partnerships include Cigna and large regional plans.

High Client Diversification and Growth in Covered Lives

Progyny reported 532 clients and an average of 6.7 million covered lives, with diversification across 45 industries, showing resilience and growth even after losing a large client.

Progyny (PGNY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

PGNY Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Jul 31, 2025	2025 (Q2)	0.16 / -	0.17	―	―	―
May 08, 2025	2025 (Q1)	0.19 / 0.17	0.17	0.00% (0.00)	―
Feb 27, 2025	2024 (Q4)	0.10 / 0.12	0.13	-7.69% (-0.01)	―
Nov 12, 2024	2024 (Q3)	0.14 / 0.11	0.16	-31.25% (-0.05)	―
Aug 06, 2024	2024 (Q2)	0.17 / 0.17	0.15	13.33% (+0.02)	―
May 09, 2024	2024 (Q1)	0.13 / 0.17	0.18	-5.56% (>-0.01)	―
Feb 27, 2024	2023 (Q4)	0.11 / 0.13	0.03	333.33% (+0.10)	―
Nov 07, 2023	2023 (Q3)	0.12 / 0.16	0.13	23.08% (+0.03)	―
Aug 03, 2023	2023 (Q2)	0.10 / 0.15	0.09	66.67% (+0.06)	―
May 08, 2023	2023 (Q1)	0.07 / 0.18	0.05	260.00% (+0.13)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

PGNY Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 08, 2025	$23.37	$21.19	-9.33%
Feb 27, 2025	$22.88	$22.53	-1.53%
Nov 12, 2024	$17.18	$13.90	-19.09%
Aug 06, 2024	$25.74	$20.85	-19.00%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Progyny (PGNY) report earnings?

Progyny (PGNY) is schdueled to report earning on Jul 31, 2025, After Close (Confirmed).

What is Progyny (PGNY) earnings time?

Progyny (PGNY) earnings time is at Jul 31, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is PGNY EPS forecast?

PGNY EPS forecast for the fiscal quarter 2025 (Q2) is 0.16.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing